- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02411058
Attention to Incentives
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Summary:
In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on AchieveMint users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.
Information:
The experimental conditions will vary the type and amount of information about incentives as follows:
- Condition 1 - Uninformed: Users will receive 20x their usual incentives for two weeks, but will receive no emails informing them about the incentive program. (They may find out about incentives through the Achievemint platform.)
- Condition 2 - Informed about Incentives and Purpose: Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. Condition 2 will most closely resemble the "constant" condition in the previous experiment. Roughly the same initial announcement email will go out. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.
Mock-ups of the email announcements and reminders are shown below.
Incentives:
The investigators' incentives will consist of multipliers for points offered via Achievemint. Since the investigators found in the investigators' last experiment that the constant incentives were the most successful, the investigators will offer these incentives to all treated participants: 20x multipliers for 14 days.
Other details:
The other details of the experiment will be the same as the previous experiment:
- Length of incentives: the investigators will offer incentives for 14 days.
- Post-intervention observation: the investigators will observe all treatment groups for at least 30 days after the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
Exclusion Criteria:
- top 30 percentiles of active walkers
- To the extent possible, given the investigators' target sample size, the investigators will exclude users who were enrolled in the investigators' previous experiment.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Uninformed
Condition 1
|
Users will receive 20x their usual incentives for two weeks, but will either receive no emails informing them about the incentive program.
|
|
Experimental: Informed about Incentives and Purpose
Condition 2
|
Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program).
These emails will contain information about the incentives and the purpose of the incentives.
The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of steps taken
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine L. Milkman, Ph.D., University of Pennsylvania
- Principal Investigator: Bradford Tuckfield, University of Pennsylvania
- Principal Investigator: Leslie K. John, Ph.D., HBS
- Principal Investigator: Francesco Gino, Ph.D., HBS
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 819369
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Informed and Uninformed Incentives
-
Barts & The London NHS TrustCompletedQuality Improvement | Informed ConsentUnited Kingdom
-
Maharajgunj Medical CampusCompletedInformed Consent | Patient and Caregiver SatisfactionNepal
-
Nationwide Children's HospitalCompletedImproving Informed Consent ProcessUnited States
-
Johns Hopkins UniversityCompletedAsthma | Tobacco Smoking | IncentivesUnited States
-
Rowan UniversityNational Development and Research Institutes, Inc.CompletedContingent Versus Noncontingent Incentives
-
Hennepin Healthcare Research InstituteCompletedInformed ConsentUnited States
-
Erasmus Medical CenterHealth Holland; NovaCairCompletedAnxiety | Anesthesia | Education | Informed Consent | MultimediaNetherlands
-
Duke-NUS Graduate Medical SchoolSingapore General HospitalCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingCataract and IOL Surgery | VR-based Informed Consent
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingCataract and IOL Surgery | VR-based Informed Consent
Clinical Trials on Uninformed
-
The University of Hong KongCompleted
-
Emory UniversitySomaLogic, Inc.CompletedDiabetes Mellitus, Type 2United States
-
University of Colorado, DenverSomaLogic, Inc.CompletedCardiovascular Diseases | Type 2 DiabetesUnited States